← All companies
HALOZYME THERAPEUTICS, INC.
HALO - Company ID 0001159036
Market cap$9.33 B
Rank#998
Filings1,479
The table below shows HALOZYME THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $309.75M | $419.67M | $61.86M | $176.33M | $154.32M | $187.86M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $457.99M | $343.54M | $315.07M | $304.02M | $273.06M | $210.42M |
| Inventory | $155.47M | $185.80M | $181.50M | $164.87M | $131.41M | $159.31M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.